Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012360) titled 'A Randomized Controlled Trial Comparing Salvage Radiotherapy and Enzalutamide in Patients with High-risk Biochemical Recurrence or PSA Persistence after Radical Prostatectomy' on July 30.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Chung-Ang Univerisity Hospital
Condition:
Neoplasms
Intervention:
Drug : Screening will be performed for patients with high-risk biochemical recurrence (PSADT =12 months) or persistent PSA (=0.1 ng/mL) following radical prostatectomy who have provided written infor...